GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Issuance of Debt

NKGen Biotech (NKGen Biotech) Issuance of Debt : $1.53 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Issuance of Debt?

NKGen Biotech's Issuance of Debt for the three months ended in Mar. 2024 was $1.47 Mil.

NKGen Biotech's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was $1.53 Mil.


NKGen Biotech Issuance of Debt Historical Data

The historical data trend for NKGen Biotech's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Issuance of Debt Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Issuance of Debt
20.50 23.00 26.51

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Issuance of Debt Get a 7-Day Free Trial 5.50 5.60 - 0.06 1.47

NKGen Biotech Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NKGen Biotech Issuance of Debt Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


NKGen Biotech (NKGen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.